Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Serco H1 revenue and profits decline, maintains FY guidance

(Sharecast News) - Shares in public services provider Serco were in the red on Thursday after the group revealed that both revenue and profits had fall in the six months ended 30 June. Serco said interim revenues had contracted from £2.47bn to £2.35bn, while underlying profits were down 4% year-on-year at £142.0m and reported operating profits slumped 31% to £130.0m.

Despite the H1 profit decline, the FTSE 250-listed group hiked its interim dividend by 18% year-on-year to 1.34p per share and said the remaining £83.0m of its £140.0m share buyback would be completed during H2.

Serco reiterated its full-year guidance as it said its focus on productivity and driving improvement across its portfolio had already "seen good progress at this early stage", with £1.9bn of new wins leaving its order book at a "strong" £13.5bn.

Chief executive Mark Irwin said: " Our focus on productivity and driving improvement across our portfolio has seen good progress at this early stage.

"While mindful of a potential impact internationally from elections in 2024, we are confident about the quality of our pipeline of potential new work to achieve our medium-term growth targets."

As of 1215 BST, Serco shares had slumped 7.05% to 178.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.